Biotest AG Sustainability Reports
Biotest specializes in the development and manufacture of biological therapeutics derived from human blood plasma. Its products include immunoglobulins, coagulation factors, and albumin used to treat disorders of the immune and hematopoietic systems.
Sector: Manufacturing
Country: Germany
Exchange: Deutsche Börse (Xetra)
LEI: 529900JVX7RPXBLYUD89
22 reports from 2017 to 2025
